Companies making proteins in plants are cooking along, while the agbiotech continues to give itself a black eye. Jeff L. Fox reports.
This is a preview of subscription content, log in via an institution to check access.
Author information
Authors and Affiliations
Related links
Related links
Related links in Nature Research
Beer giant blindsides Ventria's pharmacrop
Agbiotech firms realign product focus
Web links
Rights and permissions
About this article
Cite this article
Fox, J. Turning plants into protein factories. Nat Biotechnol 24, 1191–1193 (2006). https://doi.org/10.1038/nbt1006-1191
Published:
Issue Date:
DOI: https://doi.org/10.1038/nbt1006-1191
- Springer Nature America, Inc.
This article is cited by
-
Immunotherapeutic effects of recombinant colorectal cancer antigen produced in tomato fruits
Scientific Reports (2022)
-
Development of spirulina for the manufacture and oral delivery of protein therapeutics
Nature Biotechnology (2022)
-
Plant-derived EpCAM antigen induces protective anti-cancer response
Cancer Immunology, Immunotherapy (2008)
-
Effects of culture media on hCTLA4Ig production and protein expression patterns in transgenic rice cell suspension cultures
Biotechnology and Bioprocess Engineering (2008)
-
Transgenic plants for animal health: plant-made vaccine antigens for animal infectious disease control
Phytochemistry Reviews (2008)